biflorin and Melanoma

biflorin has been researched along with Melanoma* in 3 studies

Other Studies

3 other study(ies) available for biflorin and Melanoma

ArticleYear
Biflorin induces cytotoxicity by DNA interaction in genetically different human melanoma cell lines.
    Toxicology in vitro : an international journal published in association with BIBRA, 2016, Volume: 34

    Cancer is a public health problem and the second leading cause of death worldwide. The incidence of cutaneous melanoma has been notably increasing, resulting in high aggressiveness and poor survival rates. Taking into account the antitumor activity of biflorin, a substance isolated from Capraria biflora L. roots that is cytotoxic in vitro and in vivo, this study aimed to demonstrate the action of biflorin against three established human melanoma cell lines that recapitulate the molecular landscape of the disease in terms of genetic alterations and mutations, such as the TP53, NRAS and BRAF genes. The results presented here indicate that biflorin reduces the viability of melanoma cell lines by DNA interactions. Biflorin causes single and double DNA strand breaks, consequently inhibiting cell cycle progression, replication and DNA repair and promoting apoptosis. Our data suggest that biflorin could be considered as a future therapeutic option for managing melanoma.

    Topics: Cell Line, Tumor; Cell Survival; DNA; DNA Modification Methylases; DNA Repair Enzymes; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Mutation; Naphthoquinones; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins B-raf; ras Proteins; Thymidylate Synthase; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2016
A novel o-naphtoquinone inhibits N-cadherin expression and blocks melanoma cell invasion via AKT signaling.
    Toxicology in vitro : an international journal published in association with BIBRA, 2013, Volume: 27, Issue:7

    The down-regulation or loss of epithelial markers is often accompanied by the up-regulation of mesenchymal markers. E-cadherin generally suppresses invasiveness, whereas N-cadherin promotes invasion and metastasis in vitro. The aim of this work is to investigate the role of biflorin, a naphthoquinone with proven anticancer properties, on the expression of N-cadherin and AKT proteins in MDA-MB-435 invasive melanoma cancer cells after 12h of exposure to 1, 2.5 and 5 μM biflorin. Biflorin inhibited MDA-MB-435 invasion in a dose-dependent manner (p<0.01). Likewise, biflorin down-regulated N-cadherin and AKT-1 expression in a dose-dependent manner. Biflorin did not inhibit the adhesion of MDA-MB-435 cells to any tested substrates. Additionally, biflorin blocked the invasiveness of cells by down-regulating N-cadherin, most likely via AKT-1 signaling. As such, biflorin may be a novel anticancer agent and a new prototype for drug design.

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cadherins; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Melanocytes; Melanoma; Mice; Naphthoquinones; Neoplasm Proteins; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction

2013
The in-vitro and in-vivo inhibitory activity of biflorin in melanoma.
    Melanoma research, 2011, Volume: 21, Issue:2

    Biflorin, an ortho-naphthoquinone, is an active compound found in the roots of Capraria biflora L. It has been reported that biflorin presents anticancer activity, inhibiting both tumor cell line growth in culture and tumor development in mice. The aim of this study was to examine the effectiveness of biflorin treatment using both in-vitro and in-vivo melanoma models. Biflorin displayed considerable cytotoxicity against all tested cell lines, with half maximal inhibitory concentration values ranging from 0.58 μg/ml in NCI H23 (human lung adenocarcinoma) to 14.61 μg/ml in MDA-MB-231 (human breast cancer) cell lines. In a second set of experiments using B16 melanoma cells as a model, biflorin reduced cell viability but did not cause significant increase in the number of nonviable cells. In addition, the DNA synthesis was significantly inhibited. Flow cytometry analysis showed that biflorin may lead to an apoptotic death in melanoma cells, inducing DNA fragmentation and mitochondria depolarization, without affecting membrane integrity. In B16 melanoma-bearing mice, administration of biflorin (25mg/day) for 10 days inhibited tumor growth, and also increased the mean survival rate from 33.3±0.9 days (control) to 44.5±3.4 days (treated). Our findings suggest that biflorin may be considered as a promising lead compound for designing new drugs to be used in the treatment of melanoma.

    Topics: Animals; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Naphthoquinones; Skin Neoplasms

2011